# Dasatinib 50 mg Medicine Information in Liverpool and Manchester, UK – Gaytri Pharma
Dasatinib 50 mg Medicine Information Liverpool & Manchester | Gaytri Pharma
Explore Dasatinib 50 mg medicine information in Liverpool and Manchester, UK. Learn about its uses, dosage guidance, side effects, precautions, warnings and treatment safety from Gaytri Pharma.
`dasatinib-50mg-medicine-information-liverpool-manchester`
## Introduction
Dasatinib 50 mg is a prescription medicine belonging to the tyrosine kinase inhibitor (TKI) category. It is used to treat certain types of blood cancer, including chronic myeloid leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).
For patients and healthcare information seekers in **Liverpool and Manchester, UK**, understanding Dasatinib's medical uses, treatment precautions, possible adverse effects and monitoring requirements is important.
Gaytri Pharma provides pharmaceutical product information and supports international pharmaceutical business enquiries in accordance with applicable regulatory requirements.
## What Is Dasatinib 50 mg Used For?
Dasatinib works by blocking abnormal proteins involved in the growth and multiplication of certain cancer cells.
Doctors may prescribe Dasatinib for:
- Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML).
- Certain phases of chronic myeloid leukaemia.
- Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL).
- Selected paediatric leukaemia treatment regimens under specialist supervision.
Treatment suitability depends on the patient's diagnosis, age, medical history and response to previous therapies.
## Dasatinib 50 mg Tablet – Product Information
| Product detail | Information |
|---|---|
| Generic name | Dasatinib |
| Strength | 50 mg |
| Dosage form | Film-coated tablet |
| Medicine category | Tyrosine kinase inhibitor |
| Administration | Oral |
| Therapeutic area | Oncology and haematology |
| Prescription status | Prescription-only medicine |
**Important:** Dasatinib 50 mg is a tablet strength and does not indicate a universal daily dose. The treating specialist determines the appropriate dosage.
## How Does Dasatinib Work?
Dasatinib targets abnormal signalling proteins, including BCR-ABL, that contribute to the development of certain leukaemias.
By inhibiting these proteins, Dasatinib helps control the growth and multiplication of abnormal blood cells.
Regular medical assessments and blood tests are important for evaluating treatment response and monitoring safety.
## Dosage and Administration Guidelines
Dasatinib should only be taken according to a qualified specialist's prescription.
Important administration considerations include:
- Follow the prescribed dose and schedule.
- Swallow tablets whole.
- Do not crush, chew or divide tablets.
- Follow professional instructions regarding food.
- Avoid grapefruit and grapefruit juice.
- Do not independently increase or decrease the dose.
- Never discontinue treatment without medical advice.
The prescribed dosage depends on the patient's condition, response and treatment tolerance.
## Side Effects of Dasatinib 50 mg
Possible side effects include:
- Nausea and vomiting.
- Diarrhoea.
- Headache.
- Fatigue.
- Skin rash.
- Muscle and joint pain.
- Fluid retention.
- Shortness of breath.
- Reduced blood cell counts.
**Serious safety warnings:** Dasatinib may cause severe bleeding, infections, fluid accumulation around the lungs, pulmonary arterial hypertension and heart-related complications.
Seek urgent medical attention if severe breathing difficulties, unusual bleeding, chest pain or serious infection symptoms develop.
## Precautions and Drug Interactions
Before starting Dasatinib treatment, patients should inform their healthcare professional about:
1. Existing heart or lung conditions.
2. Liver problems.
3. Previous bleeding disorders.
4. Pregnancy or breastfeeding.
5. All prescription and non-prescription medicines.
6. Herbal supplements and other treatments.
Certain antifungal medicines, antibiotics and other drugs can interact with Dasatinib by affecting CYP3A4 activity. A doctor or pharmacist should review all medicines before treatment begins.
## Dasatinib Medicine Information in Liverpool and Manchester
### Dasatinib 50 mg Information in Liverpool, UK
Patients and healthcare information seekers in Liverpool can consult qualified haematologists and oncology specialists for information about CML, Ph+ ALL and Dasatinib treatment.
Professional guidance is important for understanding prescription requirements, treatment suitability, blood monitoring and possible adverse effects.
### Dasatinib 50 mg Information in Manchester, UK
People in Manchester looking for Dasatinib 50 mg medicine information should consult their oncology team for guidance about treatment options, precautions, interactions and ongoing monitor
